Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia
Clinical trial NCT00289562 · COMPLETED
Trial details
- NCT number
- NCT00289562
- Sponsor
- BioCryst Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2007-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.